Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar

Tropical Medicine and International Health

Volumn 9, Issue 11, 2004, Pages 1184-1190

  Smithuis, Frank ^a   Shahmanesh, Maryam ^a   Kyaw, Moe Kyaw ^a   Savran, Olivia ^a   Lwin, Saw ^b   White, Nicholas J ^c,d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Vector Borne Disease Control   (Myanmar)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Artesunate; Malaria; Mefloquine; Myanmar; P. falciparum

Indexed keywords

ARTEMETHER; ARTESUNATE; CHLOROQUINE; ELOQUINE; FANSIDAR; HEMOGLOBIN; MEFLOQUINE;

COMPARATIVE STUDY; DISEASE CONTROL; DRUG PRESCRIBING; MALARIA;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; MYANMAR; OPEN STUDY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; SOUTHEAST ASIA; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; MYANMAR; PYRIMETHAMINE; RECURRENCE; SESQUITERPENES; SULFADOXINE; TREATMENT FAILURE;

ASIA; EASTERN HEMISPHERE; EURASIA; KACHIN; MYANMAR; SOUTHEAST ASIA; WORLD;

ARTESUNATE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 9644300987     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01323.x     Document Type: Article

References (14)

1. Aung-Than-Batu H, Nyun R, Tin F, Myint T & Kyi KK (1975) Chloroquine-resistant malaria in Burma. Journal Tropical Medicine and Hygiene 78, 186-189.
2. ter Kuile F, Nosten F, Thieren M et al. (1992) High dose mefloquine in the treatment of multidrug resistant falciparum malaria. Journal of Infectious Diseases 166, 1393-1400.
3. Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S & White NJ (2001) Contribution of humoral immunity to the therapeutic response in falciparum malaria. American Journal of Tropical Medicine and Hygiene 65, 918-923.
4. Nosten F, van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand; a prospective study. Lancet 356, 297-302.
5. Rab MA, Freeman TW, Durrani N, de Poerck D & Rowland MW (2001) Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. Annals of Tropical Medicine and Parasitology 95, 41-46.
6. Rahman MR, Paul DC, Rashid M et al. (2001) A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh-narrowing the options for the National Malaria Control Programme. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 661-667.
7. Singhasivanon P (1999) Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian Journal of Tropical Medicine and Public Health 30 (Suppl. 4), 1-101.
8. Smithuis FM, Monti F, Grundl M et al. (1997) In vivo sensitivity of Plasmodium falciparum to chloroquine, sulfadoxine/pyrimethamine and mefloquine in Rakhine State, Western Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 468-472.
9. Tin F & Hlaing N (1977) Resistance to antimalarials by Plasmodium falciparum in Burma. Southeast Asian Journal of Tropical Medicine and Public Health 8, 104-112.
10. Tin F, Hlaing N, Lim MA, Win S & Lasserre R (1987) Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 910-912.
11. Wongsrichanalai C, Lin K, Pang LW et al. (2001) In vitro susceptibility of flasmodium falciparum isolates from Myanmar to antimalarial drugs. American Journal of Tropical Mededicine and Hygiene 65, 450-455.
12. World Health Organization (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96.1077.
13. World Health Organization, Control of Tropical Diseases (1990) Severe and complicated malaria, 2nd edn. Transactions of the Royal Society of Tropical Medicine and Hygiene 84 (Suppl. 2): 1-65.
14. Yang HL, Liu DQ, Yang YM et al. (1997) In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas. Southeast Asian Journal of Tropical Medicine and Public Health 28, 460-464.